PowerUp Acquisition (PWUP) Competitors $0.64 -0.02 (-3.03%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PWUP vs. LSB, LPCN, MTEX, SNTI, CGTX, INAB, NXTC, MIRA, BCAB, and GLYCShould you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Lakeshore Biopharma (LSB), Lipocine (LPCN), Mannatech (MTEX), Senti Biosciences (SNTI), Cognition Therapeutics (CGTX), IN8bio (INAB), NextCure (NXTC), MIRA Pharmaceuticals (MIRA), BioAtla (BCAB), and GlycoMimetics (GLYC). These companies are all part of the "pharmaceutical products" industry. PowerUp Acquisition vs. Lakeshore Biopharma Lipocine Mannatech Senti Biosciences Cognition Therapeutics IN8bio NextCure MIRA Pharmaceuticals BioAtla GlycoMimetics PowerUp Acquisition (NASDAQ:PWUP) and Lakeshore Biopharma (NASDAQ:LSB) are both small-cap manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Which has more risk & volatility, PWUP or LSB? PowerUp Acquisition has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500. Comparatively, Lakeshore Biopharma has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Do insiders and institutionals have more ownership in PWUP or LSB? 19.2% of PowerUp Acquisition shares are owned by institutional investors. Comparatively, 52.6% of Lakeshore Biopharma shares are owned by institutional investors. 48.0% of PowerUp Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to PWUP or LSB? In the previous week, PowerUp Acquisition and PowerUp Acquisition both had 1 articles in the media. Lakeshore Biopharma's average media sentiment score of 1.87 beat PowerUp Acquisition's score of 0.00 indicating that Lakeshore Biopharma is being referred to more favorably in the news media. Company Overall Sentiment PowerUp Acquisition Neutral Lakeshore Biopharma Very Positive Which has stronger valuation & earnings, PWUP or LSB? PowerUp Acquisition has higher earnings, but lower revenue than Lakeshore Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPowerUp AcquisitionN/AN/AN/AN/AN/ALakeshore Biopharma$672.27M0.03-$61.09MN/AN/A Is PWUP or LSB more profitable? Company Net Margins Return on Equity Return on Assets PowerUp AcquisitionN/A N/A N/A Lakeshore Biopharma N/A N/A N/A Does the MarketBeat Community believe in PWUP or LSB? PowerUp Acquisition and Lakeshore Biopharma both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPowerUp AcquisitionN/AN/ALakeshore BiopharmaN/AN/A SummaryLakeshore Biopharma beats PowerUp Acquisition on 4 of the 5 factors compared between the two stocks. Remove Ads Get PowerUp Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWUP vs. The Competition Export to ExcelMetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$4.97M$444.26M$2.07B$7.84BDividend YieldN/A7.51%2.67%4.01%P/E RatioN/A2.2023.5118.73Price / SalesN/A58.6277.1490.75Price / CashN/A69.01N/A34.64Price / BookN/A3.511.944.23Net IncomeN/A$35.22M-$463.10M$247.47M7 Day Performance1.52%0.24%-1.75%-2.29%1 Month Performance-63.22%-1.34%-3.41%-5.81%1 Year Performance-94.19%16.53%3.04%-0.96% PowerUp Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWUPPowerUp AcquisitionN/A$0.64-3.0%N/A-94.2%$4.97MN/A0.00N/ANews CoverageHigh Trading VolumeLSBLakeshore Biopharma1.499 of 5 stars$2.05+2.3%N/AN/A$19.03M$672.27M0.00773Positive NewsLPCNLipocine2.075 of 5 stars$3.50+4.5%$10.00+185.7%-36.9%$18.72M$7.92M-4.6110MTEXMannatech0.6999 of 5 stars$9.92-3.0%N/A+7.4%$18.70M$121.55M-12.25250Earnings ReportAnalyst ForecastGap UpSNTISenti Biosciences3.6902 of 5 stars$3.87+10.9%$10.00+158.4%-9.0%$18.69M$2.56M-0.254Short Interest ↓Positive NewsGap UpCGTXCognition Therapeutics3.7383 of 5 stars$0.45-0.1%$8.30+1,757.2%-77.2%$18.57MN/A-0.4620Short Interest ↓Analyst RevisionGap UpINABIN8bio3.034 of 5 stars$0.23+0.4%$6.75+2,884.1%-83.4%$18.38MN/A-0.3020Short Interest ↑Gap UpNXTCNextCure4.5359 of 5 stars$0.64-7.0%$3.50+446.4%-77.6%$17.94MN/A-0.3190Gap UpMIRAMIRA Pharmaceuticals1.9682 of 5 stars$1.08-8.5%$14.00+1,196.3%-3.6%$17.89MN/A-1.932Earnings ReportShort Interest ↑BCABBioAtla2.1189 of 5 stars$0.36+4.9%$6.00+1,564.4%-89.1%$17.43M$11M-0.2160Earnings ReportShort Interest ↑News CoverageGap DownGLYCGlycoMimetics1.8072 of 5 stars$0.27+2.1%$8.00+2,870.7%-92.7%$17.37M$10,000.000.0050 Remove Ads Related Companies and Tools Related Companies LSB Competitors LPCN Competitors MTEX Competitors SNTI Competitors CGTX Competitors INAB Competitors NXTC Competitors MIRA Competitors BCAB Competitors GLYC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PWUP) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PowerUp Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PowerUp Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.